new technologies competing with glp-1 medications 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Agonists Weight Loss Drugs

PlexusDx Semaglutide Injection starting at $149/mo can be restarted whenever your healthcare team clears you

But the muscle didn't

They are prepared using active pharmaceutical ingredients under the direction of a prescribing clinician

The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average

Older adults tend to benefit from a higher protein intake to counteract age-related muscle loss (sarcopenia)

PlexusDx supports personalized evaluation by combining biomarker context, genetic predisposition screening, and compounded medication options with healthcare provider guidance